Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Psychology & Psychotherapy|March 9, 2010
Tailoring a cognitive behavioural model for unexplained physical symptoms to patient's perspective: a bottom-up approachLyonne N L Zonneveld, Hugo J Duivenvoorden, Jan Passchier, et al.
Patient Preference and Adherence|October 29, 2014
How to study determinants related to medication adherence in newly diagnosed polyarthritis patients for the development of a prediction instrumentAnnelieke Pasma, Johanna Mw Hazes, Jolanda J Luime, et al.
Pain|July 4, 2009
Is there an association between psychological factors and the Complex Regional Pain Syndrome type 1 (CRPS1) in adults? A systematic reviewAnnemerle Beerthuizen, Adriaan van 't Spijker, Frank J P M Huygen, et al.
BMC Public Health|July 22, 2009
The effectiveness of a training for patients with unexplained physical symptoms: protocol of a cognitive behavioral group training and randomized controlled trialLyonne N L Zonneveld, Adriaan van 't Spijker, Jan Passchier, et al.
BMC Neurology|June 28, 2013
The effectiveness of problem solving therapy for stroke patients: study protocol for a pragmatic randomized controlled trialMarieke M Visser, Majanka H Heijenbrok-Kal, Adriaan van 't Spijker, et al.
BMC Health Services Research|December 19, 2013
Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burdenLyonne N L Zonneveld, Mirjam A G Sprangers, Cornelis G Kooiman, et al.
BMC Public Health|October 9, 2012
Predicting the outcome of a cognitive-behavioral group training for patients with unexplained physical symptoms: a one-year follow-up studyLyonne N L Zonneveld, Yanda R van Rood, Cornelis G Kooiman, et al.
Plos One|September 9, 2022
Discussing prognosis and the end of life with patients with advanced cancer or COPD: A qualitative studyCatherine Owusuaa, Liza G G van Lent, Adriaan van 't Spijker, et al.
The Journal of Rheumatology|December 17, 2014
Facilitators and barriers to adherence in the initiation phase of Disease-modifying Antirheumatic Drug (DMARD) use in patients with arthritis who recently started their first DMARD treatmentAnnelieke Pasma, Adriaan van 't Spijker, Jolanda J Luime, et al.
Rheumatology (Oxford, England)|June 30, 2016
Nonadherence to disease modifying antirheumatic drugs in the first year after diagnosis: comparing three adherence measures in early arthritis patientsAnnelieke Pasma, Ethan den Boer, Adriaan van 't Spijker, et al.
Pageof 2